William F Doyle - Net Worth and Insider Trading
William F Doyle Net Worth
The estimated net worth of William F Doyle is at least $18 Million dollars as of 2024-12-29. William F Doyle is the Executive Chairman of NovoCure Ltd and owns about 551,176 shares of NovoCure Ltd (NVCR) stock worth over $17 Million. William F Doyle is the Director of Elanco Animal Health Inc and owns about 76,330 shares of Elanco Animal Health Inc (ELAN) stock worth over $920,540. William F Doyle is also the Director of Minerva Neurosciences Inc and owns about 3,264 shares of Minerva Neurosciences Inc (NERV) stock worth over $7,377. Details can be seen in William F Doyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William F Doyle has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William F Doyle
William F Doyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William F Doyle owns 7 companies in total, including NovoCure Ltd (NVCR) , Minerva Neurosciences Inc (NERV) , and OptiNose Inc (OPTN) among others .
Click here to see the complete history of William F Doyle’s form 4 insider trades.
Insider Ownership Summary of William F Doyle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | director & 10 percent owner |
NERV | Minerva Neurosciences Inc | 2019-06-27 | director |
OPTN | OptiNose Inc | 2017-10-12 | director & 10 percent owner |
2015-02-03 | director | ||
2024-05-21 | director | ||
2022-07-11 | director | ||
2022-07-11 | director |
William F Doyle Latest Holdings Summary
William F Doyle currently owns a total of 3 stocks. Among these stocks, William F Doyle owns 551,176 shares of NovoCure Ltd (NVCR) as of August 2, 2022, with a value of $17 Million and a weighting of 94.8%. William F Doyle owns 76,330 shares of Elanco Animal Health Inc (ELAN) as of May 21, 2024, with a value of $920,540 and a weighting of 5.16%. William F Doyle also owns 3,264 shares of Minerva Neurosciences Inc (NERV) as of June 27, 2019, with a value of $7,377 and a weighting of 0.04%.
Latest Holdings of William F Doyle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | 551,176 | 30.70 | 16,921,103 |
ELAN | Elanco Animal Health Inc | 2024-05-21 | 76,330 | 12.06 | 920,540 |
NERV | Minerva Neurosciences Inc | 2019-06-27 | 3,264 | 2.26 | 7,377 |
Holding Weightings of William F Doyle
William F Doyle Form 4 Trading Tracker
According to the SEC Form 4 filings, William F Doyle has made a total of 12 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in NovoCure Ltd is the sale of 837 shares on August 2, 2022, which brought William F Doyle around $58,305.
According to the SEC Form 4 filings, William F Doyle has made a total of 2 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 15,000 shares on May 21, 2024, which cost William F Doyle around $254,700.
According to the SEC Form 4 filings, William F Doyle has made a total of 0 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 438 shares on June 27, 2019, which cost William F Doyle around $19,250.
Insider Trading History of William F Doyle
- 1
William F Doyle Trading Performance
GuruFocus tracks the stock performance after each of William F Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William F Doyle is -2.31%. GuruFocus also compares William F Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by William F Doyle within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William F Doyle's insider trading performs compared to the benchmark.
Performance of William F Doyle
William F Doyle Ownership Network
William F Doyle Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
William F Doyle is the director & 10 percent owner of NovoCure Ltd. Other key executives at NovoCure Ltd include President & CNS Cancers US Frank X Leonard , Chief Human Resources Officer Michal Nath Puri , and Chief Financial Officer Ashley Cordova .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, William F Doyle made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 5,195 shares made by Frank X Leonard , and a net sale of 2,715 shares made by Ashley Cordova .
In summary, during the past 3 months, insiders sold 1,612 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 1,612 shares. During the past 18 months, 18,392 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,392 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
William F Doyle Mailing Address
Above is the net worth, insider trading, and ownership report for William F Doyle. Currently GuruFocus does not have mailing address information for William F Doyle.